Reuters logo
7 months ago
BRIEF-Yichang Hec Changjiang Pharma updates on clinical trial approval by China FDA for a drug
December 12, 2016 / 2:43 PM / 7 months ago

BRIEF-Yichang Hec Changjiang Pharma updates on clinical trial approval by China FDA for a drug

1 Min Read

Dec 12 (Reuters) - Yichang Hec Changjiang Pharmaceutical Co Ltd

* phases ii/iii clinical trial approval granted for "yimitasvir phosphate" by china food and drug administration Source text (bit.ly/2gRidgD) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below